About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hybrid L24 New Enrollment Post Approval Study

Hybrid L24 New Enrollment Post Approval Study

NCT02379819·19 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Cochlear

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Ear to Be Implanted:
Normal to moderate hearing loss in the low frequencies with severe to profound mid to high frequency hearing loss in the ear to be implanted
CNC word recognition of 10-60% in the ear to be implanted
Contralateral Ear:
Moderately severe to profound mid to high frequency hearing loss in the contralateral ear
CNC word recognition equal to or better than that in the ear to be implanted but not more than 80% correct

You may not be if

not proficient in English
unwilling and/or unable to comply with the test protocol
deafness due to lesions of the acoustic nerve or central auditory pathway.
active middle-ear disease, with or without tympanic membrane perforation.
absence of cochlear development.
duration of severe to profound hearing loss of 30 years or greater

The record

StatusCompleted

PhaseNo phase

Taking part52

StartedFeb 2015

UpdatedMar 13, 2023

Conditions

High Frequency Sensorineural Hearing Loss

Where19

Arizona Ear Center
Phoenix, Arizona, United States
Kaiser Permanente South Sacramento
Sacramento, California, United States
University of Colorado Hospitals
Aurora, Colorado, United States